What You Need to Know About the COVID-19 Vaccine
Many pharmaceutical companies urgently began developing a COVID-19 vaccine earlier this year to reduce the spread of the virus as the threat of a pandemic loomed. Fast forward several months and ...
Many pharmaceutical companies urgently began developing a COVID-19 vaccine earlier this year to reduce the spread of the virus as the threat of a pandemic loomed. Fast forward several months and ...
If there is any word to describe 2020 it is “unprecedented,” with the work of health agencies front and center since COVID-19 emerged in the U.S. But as we approach Public Health Thank You Day and ...
Conditioning school attendance on student vaccinations is an evidence-based way of maintaining and increasing vaccine coverage. State law establishes school vaccination requirements which apply not ...
In recognition of National Infant Immunization Week, ASTHO and AMCHP interviewed Michael Warren, MD, MPH, FAAP, and Associate Administrator of the Maternal and Child Health Bureau (MCHB) at the ...
Anticipating a rapid deployment of COVID-19 vaccines as they are authorized, the CDC developed COVID-19 Vaccination Program Operational Guidance in collaboration with state and local jurisdictions to ...
Each year the U.S. battles seasonal influenza, leaving millions of people sick, hospitalized, or worse. As COVID-19 cases continue to rise, it is crucial for all eligible individuals to receive a flu ...
As communities around the country continue to navigate the complexities of COVID-19 management and prevention this fall, reliable resources are needed for connecting public health leaders with the ...
While governments have faced challenges in adopting a Health in All Policies (HiAP) approach to respond to COVID-19, the impact of the public health emergency across sectors such as housing, ...
According to the federal government, a homebased individual is someone who requires the help of another person or supportive device to leave the home, someone who is advised against leaving the home ...
The disparities experienced during the COVID pandemic have brought a national focus to health equity in our nation. The attention and resources currently being provided to help address health ...
On this bonus episode of Public Health Review, we chat with Stanley Campbell, CEO and CTO EagleForce. Campbell is an expert in artificial intelligence who knows how to leverage data in the fight ...
On this bonus episode, Jim Ivey, chief operating officer at Chexout, discusses the importance of interoperability and makes the case that public health organizations need to invest in software that ...
As we anticipate the likely approval of COVID-19 vaccination for children, our nation faces the final step to bring the COVID-19 pandemic under control. If approved for children ages 5-11, the ...
On this bonus episode of Public Health Review, we discuss how a business or government can create vaccine credentials that are more sophisticated than the paper cards from CDC, but that also protect ...
Our experts on this episode also discuss that while there have been perceived challenges in the initial COVID-19 vaccine rollout, the overall effort of getting vaccines into the arms of a virus that ...
This bonus episode is taken from a virtual news conference on Thursday, July 29, 2021. In it, Nirav Shah (Maine), Karyl Rattay (Delaware), and Joseph Kanter (Louisiana), discuss the latest issues ...
Nirav Shah, Director of Maine Center for Disease Control and Prevention, and Joe Smyser, CEO of Public Good Projects, discuss countering COVID-19 vaccine misinformation.
Vaccines are one of the greatest public health achievements of the last century, as well as some of the most powerful and cost-effective tools to prevent disease, disparities, disability, and death ...
With many of the state and territorial legislatures reconvening over the next few weeks, we can look forward to new (and not-so-new) legislation start to crop up that will impact public health. To ...
States have largely dismissed weakening policies, but legislatures are likely to continue considering vaccine-related bills, which may allow public health leaders to work collaboratively toward ...